<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>Tedavi &#8211; Sigorta Haber</title>
	<atom:link href="https://www.sigortahaber.com/tag/tedavi/feed" rel="self" type="application/rss+xml" />
	<link>https://www.sigortahaber.com</link>
	<description>Sigorta haberleri, sektör analizleri, mevzuat ve sigorta rehberleri.</description>
	<lastBuildDate>Tue, 11 Aug 2026 23:00:43 +0000</lastBuildDate>
	<language>tr</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://www.sigortahaber.com/wp-content/uploads/2026/08/cropped-728951503_1547411470163353_6244899211457917653_n-32x32.webp</url>
	<title>Tedavi &#8211; Sigorta Haber</title>
	<link>https://www.sigortahaber.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Ultragenyx hissesi, Angelman sendromu ilacına FDA’dan çığır açan terapi statüsü almasıyla yükseldi</title>
		<link>https://www.sigortahaber.com/ultragenyx-hissesi-angelman-sendromu-ilacina-fdadan-cigir-acan-terapi-statusu-almasiyla-yukseldi-24400853</link>
					<comments>https://www.sigortahaber.com/ultragenyx-hissesi-angelman-sendromu-ilacina-fdadan-cigir-acan-terapi-statusu-almasiyla-yukseldi-24400853#comments</comments>
		
		<dc:creator><![CDATA[Sigorta Haber]]></dc:creator>
		<pubDate>Fri, 27 Jun 2025 13:30:03 +0000</pubDate>
				<category><![CDATA[Haberler]]></category>
		<category><![CDATA[Tedavi]]></category>
		<guid isPermaLink="false">https://www.sigortahaber.com/?p=24400853</guid>

					<description><![CDATA[Ultragenyx hissesi, Angelman sendromu ilacına FDA’dan çığır açan terapi statüsü almasıyla yükseldi]]></description>
		
					<wfw:commentRss>https://www.sigortahaber.com/ultragenyx-hissesi-angelman-sendromu-ilacina-fdadan-cigir-acan-terapi-statusu-almasiyla-yukseldi-24400853/feed</wfw:commentRss>
			<slash:comments>4</slash:comments>
		
		
		<media:content url="https://www.sigortahaber.com/wp-content/themes/seobaz-haber-temasi/assets/images/placeholder.webp" medium="image" />
	</item>
		<item>
		<title>Genç adam sigorta şirketine 5 milyonluk dava açtı</title>
		<link>https://www.sigortahaber.com/genc-adam-sigorta-sirketine-5-milyonluk-dava-acti-24384590</link>
					<comments>https://www.sigortahaber.com/genc-adam-sigorta-sirketine-5-milyonluk-dava-acti-24384590#respond</comments>
		
		<dc:creator><![CDATA[Sigorta Haber]]></dc:creator>
		<pubDate>Wed, 09 Apr 2025 10:36:03 +0000</pubDate>
				<category><![CDATA[Sigorta]]></category>
		<category><![CDATA[sigorta şirketi]]></category>
		<category><![CDATA[Tedavi]]></category>
		<guid isPermaLink="false">https://www.sigortahaber.com/?p=24384590</guid>

					<description><![CDATA[İstanbul'da Ahmet P. ömür boyu yenilememe garantisi ile özel sağlık sigortası yaptırdı. Genç adam, nadir görülen ve hayati tehlike yaratan kan hastalığına yakalandı. İddiaya göre hastane, tedavi masraflarını karşılamayarak kendisini ölüme terk etti. Ahmet P. sigorta şirketine 17 bin 715 Euro alacak ve 5 milyon TL'lik tazminat davası açtı.]]></description>
		
					<wfw:commentRss>https://www.sigortahaber.com/genc-adam-sigorta-sirketine-5-milyonluk-dava-acti-24384590/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<media:content url="https://www.sigortahaber.com/wp-content/uploads/2025/04/genc-adam-sigorta-sirketine-5-milyonluk-dava-acti-mLFvEyXf.jpg" medium="image" width="1200" height="800" />
	</item>
	</channel>
</rss>
